Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical aspects of comparative bioavailability trials.

W J Westlake

    Biometrics
    |March 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Comparative bioavailability trials are crucial for assessing drug bioequivalence. Current statistical analysis methods are often irrelevant, suggesting a shift towards estimation procedures for therapeutic equivalence.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Steady-state lithium blood level fluctuations in man following administration of a lithium carbonate conventional and controlled-release dosage form.

    Journal of clinical pharmacology·1981
    Same author

    The bladderless dog: a new animal model for use in experimental xenobiology.

    Drug metabolism reviews·1981
    Same author

    Bioavailability of cimetidine in man.

    Gastroenterology·1978
    Same author

    Symmetrical confidence intervals for bioequivalence trials.

    Biometrics·1976
    Same author

    Statistical implications in generic equivalents.

    Psychopharmacology bulletin·1976
    Same author

    Proceedings: Statistical considerations in the planning and analysis of pharmacokinetic experiments.

    Acta pharmaceutica Suecica·1975

    Area of Science:

    • Pharmacokinetics and Biopharmaceutics
    • Clinical Trial Design
    • Statistical Analysis in Medicine

    Background:

    • Comparative bioavailability trials are essential for evaluating bioequivalence between different drug formulations.
    • Current statistical methods in these trials may not directly address the core objective of therapeutic equivalence.

    Purpose of the Study:

    • To review the statistical aspects of designing and analyzing comparative bioavailability trials.
    • To propose alternative statistical approaches for assessing drug bioequivalence and therapeutic effects.

    Main Methods:

    • Review of existing literature on bioavailability trial design and analysis.
    • Discussion of the relevance of traditional hypothesis testing versus estimation procedures.

    Related Experiment Videos

    Main Results:

    • Trial design for bioavailability studies is generally straightforward.
    • Traditional null hypothesis testing is deemed irrelevant for determining therapeutic equivalence.
    • Focus should be on data characteristics directly related to therapeutic use.

    Conclusions:

    • Estimation procedures are recommended over hypothesis testing for bioavailability trials.
    • Future research should investigate further statistical aspects of these trials.
    • The goal is to ensure different drug formulations yield essentially equivalent therapeutic effects.